The slip
PARKINSON RECEIPTno. 0487
17 Oct 2026, 02:01 UTColigodendrocytes, braak
predictionNUP160 in oligodendrocytes tracks Braak Lewy-body stage
registered07a504eef8ae04a6
discovery-0.24 p=0.539 n=9
replication-0.52 p=0.150 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.24, p 0.539)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT81c847a46980fa2802d7c91f…
follows 70bf2dc8d68b…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 0487: NUP160 in oligodendrocytes, braak
- power
- full sample -0.36 (p 0.137, n 18), 95% CI -0.71 to +0.12. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.34 (p 0.170, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.37 (p 0.135, n 18). could be the mix.
- skeptic
- leave-one-out range -0.56 to -0.28, sign flips 0; without severely affected donors -0.36 (p 0.137, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NUP160 in oligodendrocytes.
case closed: nothing better to follow up.